Vaccinations
- PMID: 32091793
- Bookshelf ID: NBK553979
- DOI: 10.1007/978-3-030-02278-5_29
Vaccinations
Excerpt
Vaccination should be considered a routine practice for all HSCT receptors, either autologous or allogeneic, adults or children. It should be implemented in all HSCT programs.
Copyright 2019, EBMT and the Author(s).
Sections
- 29.1. General Concepts
- 29.2. General Principles of Vaccination in HSCT Patients
- 29.3. Benefits and Risks of Vaccination in HSCT Patients
- 29.4. Vaccination Recommendations
- 29.5. Specific Vaccines
- 29.6. Vaccinations Before Travel to Areas Endemic for Infections (See Table 29.3) (Ljungman et al. 2009)
- 29.7. Serological Testing
- 29.8. Vaccinations for Donors, Close Contacts/Family, and HCWs of HSCT Recipients (See Table 29.4) (Ljungman et al. ; Cordonnier et al. ; Rubin et al. 2014)
- References
References
-
- Beck CR, McKenzie BC, Hashim AB, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by aetiology. J Infect Dis. 2012;206:1250–9. - PubMed
-
- Cordonnier C, Cesaro S, De Lavallade H, et al. Guidelines for vaccination of patients with hematological malignancies and HSCT recipient. ECIL 2017. 2017; Published online 4-10-2017. www.ecil-leukaemia.com.
-
- Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol. 2006;48:1498–502. - PubMed
Publication types
LinkOut - more resources
Full Text Sources